Raquel Álvarez

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Medicinal research reviews

International journal of molecular sciences

Universidad de Salamanca

Universidad de Salamanca (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Salamanca Sep 26 2011 - Feb 29 2016

Spain

Profesora Ayudante Doctor :: Química Farmacéutica

Education History

Universidad de Salamanca Mar 01 2016

Spain

PHD :: Ciencias Farmacéuticas

Universidad de Salamanca - Jun 10 2009

Spain

PHD :: Química farmacéutica

Publications

Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
Sergio Ramos, Alba Vicente-Blázquez, Marta López-Rubio, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition. International journal of molecular sciences 24 (24) (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
Sergio Ramos, Alba Vicente-Blázquez, Marta López-Rubio, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition. International journal of molecular sciences 24 (24) (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
Myriam González, María Ovejero-Sánchez, Alba Vicente-Blázquez, Raquel Álvarez, Ana Belén Herrero, Manuel Medarde, Rogelio González Sarmiento, Rafael Peláez
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy. International journal of molecular sciences 22 (4) (2021)
Alba Vicente-Blázquez, Myriam González, Raquel Álvarez, Sara Del Mazo, Manuel Medarde, Rafael Peláez
Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target. Medicinal research reviews 39 (3) (2018)

Raquel Álvarez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Raquel Álvarez